SPIRIVA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SPIRIVA contains one active pharmaceutical ingredient (API):

1 Tiotropium
UNII L64SXO195N - TIOTROPIUM BROMIDE MONOHYDRATE

Tiotropium is a long-acting, specific, muscarinic receptor antagonist, in clinical medicine often called an anticholinergic. By binding to the muscarinic receptors in the bronchial smooth musculature, tiotropium inhibits the cholinergic (bronchoconstrictive) effects of acetylcholine, released from parasympathetic nerve endings.

Read about Tiotropium

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SPIRIVA Inhalation powder, hard capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SPIRIVA RESPIMAT Inhalation solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03BB04 Tiotropium bromide R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10509D, 11043F, 11629C, 8626B
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 504504204135219
Country: CA Health Products and Food Branch Identifier(s): 02246793, 02435381
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 24.913-01-03, 29123-12-09
Country: EE Ravimiamet Identifier(s): 1511301, 1511312, 1511323, 1511334, 1511345, 1511367, 1513471, 1513482, 1513493
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 64796, 69589
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 005588, 005600, 021617, 038701, 099753, 119927, 516398
Country: FR Base de données publique des médicaments Identifier(s): 60363967, 62828920
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 121470, 139527, 139535, 143829, 143844, 302937, 33788, 33805, 373950, 376778, 377301, 377434, 394089
Country: HK Department of Health Drug Office Identifier(s): 50663, 51091, 57639
Country: IE Health Products Regulatory Authority Identifier(s): 13205, 46811, 46913, 58405, 60453, 61468, 61500, 61503, 61504, 61509
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4874, 7759
Country: IT Agenzia del Farmaco Identifier(s): 035668058
Country: JP 医薬品医療機器総合機構 Identifier(s): 2259709G1027, 2259709G2023, 2259709G3020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004070, 1008917, 1008918, 1008919, 1018915, 1018916, 1025647, 1035424, 1086468, 1086469, 1086470, 1086471
Country: MT Medicines Authority Identifier(s): MA211/00201, MA211/00301
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 039M2002
Country: NL Z-Index G-Standaard, PRK Identifier(s): 59927, 84808
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10042, 13667
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100112888, 100217386
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W57488001, W57488002, W57488003, W57488004, W57488005, W57488006, W57488007, W58575005, W58575006, W58575007, W58575008
Country: SG Health Sciences Authority Identifier(s): 12238P, 13642P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 11533013, 11533014, 11533015
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699693550019
Country: US FDA, National Drug Code Identifier(s): 0597-0075, 0597-0100, 0597-0160, 50090-4248, 50090-4414
Country: ZA Health Products Regulatory Authority Identifier(s): 36/10.2.1/0044, 41/10.2.1/0849

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.